Related Experiment Videos

The Indiana experience with artificial urinary sphincters in children and young adults

C D Anthony Herndon1, Richard C Rink, Matthew B K Shaw

  • 1Pediatric Urology Department, James Whitcomb Riley Hospital for Children, Indiana University School of Medicine, Indiana 46202, USA.

The Journal of Urology
|January 25, 2003
PubMed

Insights

The artificial urinary sphincter (AUS) significantly improves continence in children and adolescents, with the AMS 800 model showing dramatically fewer mechanical complications than older versions. Lifelong follow-up is essential for all patients with an AUS.

Area of Science:

  • Pediatric Urology
  • Reconstructive Urology
  • Medical Device Technology

Background:

  • Artificial urinary sphincter (AUS) implantation is a critical treatment for urinary incontinence in pediatric patients.
  • Long-term outcomes and device-specific complications in this population require extensive evaluation.

Purpose of the Study:

  • To analyze a 22-year institutional experience with artificial urinary sphincter implantation in children and adolescents.
  • To compare the outcomes and complication rates of pre-AMS 800 and AMS 800 models.

Main Methods:

  • Retrospective review of 142 pediatric patients (median age 10 years) who underwent AUS implantation between 1980 and 2002.
  • Analysis of continence rates, mechanical and surgical complications, revisions, and secondary procedures.
  • Comparison of outcomes between older AUS models (AMS 742/792) and the AMS 800 model using statistical tests.

Main Results:

  • Continence was achieved in 86% of patients post-AUS implantation, with 92% remaining continent with the device in place.
  • Mechanical complication rates were significantly lower in the AMS 800 model (30%) compared to pre-800 models (64%).
  • Revision rates were lower for the AMS 800 model (16% vs. 25%), and revisions occurred less frequently per patient-year (44.3 vs. 22.7).

Conclusions:

  • The artificial urinary sphincter is a vital option for achieving continence in children with neuropathic bladders, allowing spontaneous voiding.
  • The AMS 800 model demonstrates a significant reduction in mechanical complications and revisions compared to earlier devices.
  • Secondary bladder augmentation was required in 28% of patients, highlighting the need for lifelong monitoring and management.
Abstract

Related Concept Videos